甲状腺半切术后甲状腺功能减退的预测因素:临床列线图的开发与验证
本研究基于791例甲状腺半切术患者的前瞻性数据库进行回顾性分析,最终纳入507例,其中46.6%在术后12个月内发生甲减,55.9%发生于术后3个月内。多因素回归识别出家族史、术前游离T3升高、TSH>2.42 μIU/mL、标本尺寸≥36.2 mm、标本甲状腺炎及癌变等独立预测因素,并构建列线图,内部验证AUC为0.745(95%CI 0.703-0.788),校准良好。
要点
- 甲状腺半切术后12个月内甲减发生率46.6%,过半发生于术后3个月内。
- 列线图基于家族史、术前FT3、TSH、标本尺寸、标本甲状腺炎及癌变预测甲减风险。
- 模型区分度AUC 0.745(95%CI 0.703-0.788),可用于术前咨询及术后监测策略。
核心结论
- 甲状腺半切术后近半数患者发生甲减,且多集中在术后3个月内。
- 基于6项独立预测因素构建的列线图经内部验证区分度良好(AUC 0.745),可用于个体化风险评估。
研究设计与样本
- 回顾性分析前瞻性维护数据库,纳入2017-2023年单中心791例甲状腺半切术患者,最终分析507例。
- 排除既往甲状腺手术、术前甲状腺激素治疗、放射性碘治疗或随访期间行全甲状腺切除者。
- 主要结局为启动左甲状腺素治疗,采用多因素logistic和Cox回归识别独立预测因素。
- 列线图通过bootstrap重抽样进行内部验证。
主要发现
- 507例中236例(46.6%)在12个月内发生甲减,其中55.9%发生于术后3个月内。
- 列线图区分度AUC 0.745(95%CI 0.703-0.788),校准良好。
关键数值与推荐
- 列线图AUC 0.745(95%CI 0.703-0.788)。
临床怎么用
- 术前可利用列线图对甲状腺半切患者进行甲减风险个体化咨询。
- 术后3个月内应加强甲状腺功能监测,尤其针对高风险患者。
- 根据风险分层制定术后随访策略,避免漏诊甲减。
局限性
- 回顾性分析单中心数据,可能存在选择偏倚。
- 列线图仅进行内部验证,缺乏外部验证。
- 样本量从791例减少至507例,排除标准可能影响代表性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypothyroidism after hemithyroidectomy remains common and may offset the perceived benefits of a less extensive operation. Reliable risk stratification tools for postoperative hypothyroidism after hemithyroidectomy are lacking. This study aimed to identify predictors of postoperative hypothyroidism and develop a clinically applicable risk model. METHODS: A retrospective analysis of a prospectively maintained database was performed, including 791 patients who underwent hemithyroidectomy at a tertiary center (2017-2023). Patients with prior thyroid surgery, preoperative thyroid hormone therapy, radioactive iodine treatment, or complete thyroidectomy during follow-up were excluded. The primary outcome was initiation of levothyroxine. Independent predictors were identified using multivariable logistic and Cox regression analyses. A nomogram was developed and internally validated using bootstrap resampling. RESULTS: Among 507 included patients, 236 (46.6%) developed hypothyroidism within 12 months; 55.9% of cases occurred within 3 months. Independent predictors included family history of thyroid disease (odds ratio, 6.63; P = .006), elevated preoperative free triiodothyronine (odds ratio, 2.45; P = .006), thyroid-stimulating hormone >2.42 μIU/mL (odds ratio, 4.23; P < .001), specimen size ≥36.2 mm (odds ratio, 10.69; P = .001), thyroiditis in the surgical specimen (odds ratio, 48.21; P = .001), and carcinoma (odds ratio, 6.02; P = .012). A nomogram incorporating these variables enabled individualized risk estimation. The model demonstrated good discrimination (area under the curve, 0.745; 95% confidence interval, 0.703-0.788) and calibration. CONCLUSION: Hypothyroidism affects nearly half of patients after hemithyroidectomy, frequently within the first 3 months. This validated nomogram provides a practical tool for preoperative counseling and may inform tailored postoperative surveillance strategies.
引用
- León AG, Rubio-Manzanares Dorado M, Bonilla Cózar MÁ, et al. Predictors of hypothyroidism after hemithyroidectomy: Development and validation of a clinical nomogram. Surgery. 2026. PMID: 42424766. doi:10.1016/j.surg.2026.110401
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。